 |
 |

Longitudinal Study on the Role of Body Size in Premenopausal Breast Cancer
Karin B. Michels, ScD, PhD;
Kathryn L. Terry, ScD;
Walter C. Willett, MD, DrPH
Arch Intern Med. 2006;166:2395-2402.
Background A high body mass index (BMI) has been related to a reduced risk of breast cancer in premenopausal women. The mechanisms underlying this association have not been elucidated.
Methods We explored whether factors affecting ovulation may explain the inverse association between BMI (calculated as weight in kilograms divided by the square of height in meters) and breast cancer in 113 130 premenopausal participants in the Nurses' Health Study II. During 1 225 520 person-years of prospective follow-up between 1989 and 2003, 1398 incident cases of invasive breast cancer were diagnosed. Weight, height, ovulatory infertility, menstrual cycle patterns, and a multitude of covariates were assessed throughout follow-up. Cox proportional hazards regression was used to compute hazard ratios and 95% confidence intervals (CIs).
Results We observed a significant linear inverse trend between current BMI and breast cancer incidence (P<.001) that was not explained by menstrual cycle characteristics or infertility due to an ovulatory disorder (covariate-adjusted hazard ratio for breast cancer in women with a BMI 30 vs 20.0-22.4, 0.81; 95% CI, 0.68-0.96). We found BMI at age 18 years to be the strongest predictor of breast cancer incidence (covariate-adjusted hazard ratio for breast cancer in women with a BMI at age 18 years 27.5 vs 20.0-22.4, 0.57; 95% CI, 0.41-0.81).
Conclusions Body size during the early phases of adult life seems to be particularly important in the development of premenopausal breast cancer. Factors other than anovulation are likely to mediate the protection conferred by a high BMI.
Author Affiliations: Department of Obstetrics and Gynecology, Obstetrics and Gynecology Epidemiology Center (Drs Michels and Terry), and Department of Medicine, Channing Laboratory (Drs Michels, Terry, and Willett), Brigham and Women's Hospital, Harvard Medical School; and Departments of Epidemiology (Drs Michels and Willett) and Nutrition (Dr Willett), Harvard School of Public Health; Boston, Mass.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Early-Life Factors and Breast Cancer Risk in Hispanic Women: the Role of Adolescent Body Size
Sangaramoorthy et al.
Cancer Epidemiol. Biomarkers Prev. 2011;20:2572-2582.
ABSTRACT
| FULL TEXT
Body Size Across the Life Course, Mammographic Density, and Risk of Breast Cancer
Harris et al.
Am J Epidemiol 2011;174:909-918.
ABSTRACT
| FULL TEXT
Plasma Leptin Levels and Risk of Breast Cancer in Premenopausal Women
Harris et al.
Cancer Prev Res 2011;4:1449-1456.
ABSTRACT
| FULL TEXT
Body Fat Distribution and Risk of Premenopausal Breast Cancer in the Nurses' Health Study II
Harris et al.
JNCI J Natl Cancer Inst 2011;103:273-278.
ABSTRACT
| FULL TEXT
Adult Body Size, Hormone Receptor Status, and Premenopausal Breast Cancer Risk in a Multiethnic Population: The San Francisco Bay Area Breast Cancer Study
John et al.
Am J Epidemiol 2011;173:201-216.
ABSTRACT
| FULL TEXT
A Population-based Case-Control Study of Fetal Growth, Gestational Age, and Maternal Breast Cancer
Nechuta et al.
Am J Epidemiol 2010;172:962-970.
ABSTRACT
| FULL TEXT
A Case-Control Study of Body Mass Index and Breast Cancer Risk in White and African-American Women
Berstad et al.
Cancer Epidemiol. Biomarkers Prev. 2010;19:1532-1544.
ABSTRACT
| FULL TEXT
Body Fatness at Young Ages and Risk of Breast Cancer Throughout Life
Baer et al.
Am J Epidemiol 2010;171:1183-1194.
ABSTRACT
| FULL TEXT
Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3
Fowke et al.
Endocr Relat Cancer 2010;17:51-60.
ABSTRACT
| FULL TEXT
Relative Weight at Age 12 and Risk of Postmenopausal Breast Cancer
Bardia et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:374-378.
ABSTRACT
| FULL TEXT
A Prospective Study of Body Size and Breast Cancer in Black Women
Palmer et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1795-1802.
ABSTRACT
| FULL TEXT
|